Carmen Charlton

Canadian Blood Services

H指数:21

被引数:1,925

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Public awareness and knowledge of blood donation eligibility and deferral criteria: Fostering a culture of donation and advancing equity

公众对献血资格和暂缓标准的认知与了解：培育献血文化并促进公平

Transfusion

IF2

2026-09-300

OAAI

How does a national blood operator detect early infectious disease signals affecting blood and cellular therapy product safety and sufficiency?

国家血液运营机构如何检测影响血液和细胞治疗产品安全性与充足性的早期传染病信号？

Transfusion

IF2

2026-09-300

OAAI

Donor management implications for high-sensitivity detection of low-level malaria parasitemia in blood donor screening

低水平疟原虫血症的高灵敏度检测在献血者筛查中的供者管理意义

Transfusion

IF2

2026-06-220

An international study on emerging arboviral infections and blood safety

关于新兴虫媒病毒感染与血液安全的一项国际研究

Transfusion

IF2

2026-06-180

OAAI

Piya Rajendra; Helen M. Faddy; Daniel Candotti; Carolina B. Bub; Jose M. Kutner; Steven J. Drews; Carmen L. Charlton; Sheila F. O'Brien; Wai-Chiu Tsoi; Michel-Andres Garcia-Otalora; Claire Reynolds; Tuulia Palukka; Riikka Lehtisalo; Ruth Offergeld; Axel Seltsam; Marijke Weber-Schehl; Nahid Chenarsabz; Naoko Goto; Sung-Chan Park; So-Yong Kwon; Ryanne Lieshout-Krikke; Aneta Kopacz; Ewa Sulkowska; Oana-Alexandra Șerban; Simona Ruta; Eugene Zhiburt; Maha Badawi; Josephine Mitchel; Ute Jentsch; Ángel Luis Pajares Herraiz; Ana Lafuente Guijosa; Gülşen Özkaya Şahin; Christoph Niederhauser; Marion C. Lanteri; Brian Custer; Galen Conti; Anthea Cheng; Shannah Secret; Peter Simmonds; Heli Harvala; the Virology subgroup of the ISBT WP-TTID

A decision-making process to guide the potential application of a hepatitis A virus and parvovirus B19 nucleic acid test for qualifying plasma for fractionation

一种指导丙型肝炎病毒和细小病毒B19核酸测试用于血浆分馏质量评估的决策过程

JOURNAL OF THE ASSOCIATION OF MEDICAL MICROBIOLOGY AND INFECTIOUS DISEASE CANADA (JAMMI)

IF1.1

2026-06-010

PRE

An in-house nucleic acid test for detection of Anaplasma phagocytophilum in whole blood donor samples

一种用于检测全血供者样本中嗜吞噬细胞无形体的人体内核糖核酸检测

Transfusion

IF2

2026-04-130

OAAI

Using blood donor surveillance and clinical case data to shape our understanding of Babesia epidemiology in Manitoba, Canada

利用献血者监测和临床病例数据来阐明加拿大马尼托巴省巴贝虫病的流行病学

Transfusion

IF2

2026-03-010

OAAI

COVID-19 antibody testing study: a nested substudy within Alberta's Tomorrow Project (ATP) in Alberta, Canada

COVID-19抗体检测研究：加拿大阿尔伯塔省阿尔伯塔未来项目(ATP)的一项巢式子研究

BMJ OPEN

IF2.3

2025-11-130

Comparability of Canadian SARS-CoV-2 seroprevalence estimates with statistical adjustment for socio-demographic representation

加拿大SARS-CoV-2血清流行率估计值的可比性：对社会人口学代表性的统计调整

Canadian Journal of Public Health

IF0.7

2025-11-100

PRE

Surveillance of Antimicrobial Resistance in Neisseria gonorrhoeae in Alberta from 2016–2022

2016–2022年阿尔伯塔省奈瑟氏淋病奈瑟菌耐药性监测

Antibiotics 2025, Vol. 14, Page 1119

IF0

2025-11-060

OAAI

How do I interpret transfusion transmissible infectious disease testing in a low-risk donor population?

如何解释在低风险献血者人群中进行的输血传播性传染病检测？

Transfusion

IF2

2025-10-090

OAAI

The impact of statistical adjustment for assay performance on inferences from SARS-CoV-2 serological surveillance studies

统计调整对SARS-CoV-2血清学监测研究结论的影响

AMERICAN JOURNAL OF EPIDEMIOLOGY

IF4.8

2025-08-011

OAAI

West Nile Virus positivity amongst Canadian blood donors and effectiveness of off-season screening

加拿大献血者中西尼罗病毒的阳性率及非季节性筛查的有效性

Transfusion

IF2

2025-06-280

OAAI

Pediatric antibody responses to SARS-CoV-2 after infection and vaccination in Calgary, Canada

加拿大卡尔加里感染和疫苗接种后儿童对SARS-CoV-2的抗体反应

BMC INFECTIOUS DISEASES

IF3

2024-07-180

OAAI

Reply to: Population-based screening works: Effect of integrating screening for hepatitis B and C into the general health check-up in Germany

答复: 基于人群的筛查工作: 将乙型和丙型肝炎筛查纳入德国的一般健康检查的效果

JOURNAL OF HEPATOLOGY

IF33

2024-04-010

PRE

Evaluation and comparison of risk-based and universal prenatal HCV screening programs in Alberta, Canada

JOURNAL OF HEPATOLOGY

IF33

2023-11-014

PRE

Molecular epidemiology of rotavirus among children in Western Canada: Dynamic changes in genotype prevalence in four consecutive seasons

JOURNAL OF MEDICAL VIROLOGY

IF4.6

2023-08-133

The evolution of SARS-CoV-2 seroprevalence in Canada: a time-series study, 2020-2023

加拿大SARS-CoV-2血清阳性率的演变: 时间序列研究，2020-2023

CANADIAN MEDICAL ASSOCIATION JOURNAL

IF11.3

2023-08-1316

OAAI

Murphy, Tanya J.; Swail, Hanna; Jain, Jaspreet; Anderson, Maureen; Awadalla, Philip; Behl, Lesley; Brown, Patrick E.; Charlton, Carmen L.; Colwill, Karen; Drews, Steven J.; Gingras, Anne-Claude; Hinshaw, Deena; Jha, Prabhat; Kanji, Jamil N.; Kirsh, Victoria A.; Lang, Amanda L. S.; Langlois, Marc-Andre; Lee, Stephen; Lewin, Antoine; O'Brien, Sheila F.; Pambrun, Chantale; Skead, Kimberly; Stephens, David A.; Stein, Derek R.; Tipples, Graham; Van Caeseele, Paul G.; Evans, Timothy G.; Oxlade, Olivia; Mazer, Bruce D.; Buckeridge, David L.

Association of COVID-19 Government-Instituted Mask Mandates With Incidence of Mask Use Among Children in Alberta, Canada

JAMA NETWORK OPEN

IF9.7

2023-06-080

OAAI

Human pegivirus viremia in HCV/HIV co-infected patients: Direct acting antivirals exert anti-pegivirus effects

HCV/HIV合并感染患者中的人类pegivirus病毒血症: 直接作用的抗病毒药物发挥抗pegivirus作用

JOURNAL OF CLINICAL VIROLOGY

IF3.4

2023-05-011

PRE

Carmen Charlton

个人简介

教育背景

工作经历

荣誉奖项

研究方向